Pfizer
PFE
$40.80
Share price
1.04%
Change (1 day)
-20.88%
Change (1 year)
Categories
Pfizer Inc., is a global pharmaceutical company headquartered in New York City, New York, United States. It was founded by Charles Pfizer from Ludwigsburg. Pfizer is the second largest pharmaceutical company in the world after Roche, followed by Novartis.
Market capitalization of Pfizer (PFE)
Market cap: $231.78 Billion
As of April 2023 Pfizer has a market cap of $231.78 Billion. This makes Pfizer the world's 38th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pfizer from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $231.78 B | -19.41% |
| 2022 | $287.62 B | -13.22% |
| 2021 | $331.43 B | 61.99% |
| 2020 | $204.60 B | -5.63% |
| 2019 | $216.82 B | -13.11% |
| 2018 | $249.54 B | 15.59% |
| 2017 | $215.89 B | 9.54% |
| 2016 | $197.10 B | -1.12% |
| 2015 | $199.32 B | 1.72% |
| 2014 | $195.96 B | -0.02% |
| 2013 | $196.00 B | 7.41% |
| 2012 | $182.47 B | 9.7% |
| 2011 | $166.34 B | 18.57% |
| 2010 | $140.29 B | -4.43% |
| 2009 | $146.79 B | 22.92% |
| 2008 | $119.41 B | -22.29% |
| 2007 | $153.67 B | -16.71% |
| 2006 | $184.51 B | 7.49% |
| 2005 | $171.65 B | -14.58% |
| 2004 | $200.94 B | -25.45% |
| 2003 | $269.53 B | 43.09% |
| 2002 | $188.37 B | -24.69% |
| 2001 | $250.13 B |
End of Day market cap according to different sources
On Apr 1st, 2023 the market cap of Pfizer was reported to be:
$230.29 Billion
$231.78 Billion
$229.02 Billion
$230.29 Billion
$230.29 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $483.57 B | 108.63% | 🇺🇸 USA |
 Novartis NVS | $195.00 B | -15.87% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $178.72 B | -22.89% | 🇺🇸 USA |
 Eli Lilly LLY | $327.05 B | 41.10% | 🇺🇸 USA |
 Amgen AMGN | $130.46 B | -43.71% | 🇺🇸 USA |
 Merck MRK | $270.08 B | 16.52% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $145.77 B | -37.11% | 🇺🇸 USA |
 AstraZeneca AZN | $215.14 B | -7.18% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $72.84 B | -68.57% | 🇬🇧 UK |